Bioanalytical Services To Accelerate Drug Development

Delivering rapid bioanalytical data is critical to drug development. From drug discovery, through to preclinical and clinical studies, understanding drug exposure and behavior are imperative to dose selection, and accelerating drugs to clinic and commercialization. Through the use of robust bioanalytical techniques, biological samples can be processed and analyzed to identify and quantify compounds of interest, such as small molecules and their metabolites, as well as peptides, proteins, nucleic acids and other analytes.

At Quotient, we are experts in the development, validation, and application of bioanalytical assays. Our dedicated team of bioanalytical chemists are globally recognized and have more than 40 years’ experience in supporting all stages of drug development, from early preclinical through to First-in-Human (FIH), and onwards to Phase II and III patient studies. We help our customers gain a clear understanding of the fate of their drug in the body, whether it is in a preclinical model, healthy volunteer, or patient.

Combining our development and validation experience of over 400 bioanalytical assays, along with our integrated service lines, we can ensure that critical decision-making data are rapidly processed, robust and reliable.